The Role of the Level of Interleukin-33 in the Therapeutic Outcomes of Immunotherapy in Patients with Allergic Rhinitis
Sign Up to like & getrecommendations! Published in 2018 at "International Archives of Otorhinolaryngology"
DOI: 10.1055/s-0037-1605596
Abstract: Introduction Allergic rhinitis (AR) affects up to 40% of the population and results in nasal itching, congestion, sneezing, and clear rhinorrhea. Objectives This study aimed to evaluate the changes in the clinical symptoms and in… read more here.
Keywords: allergic rhinitis; immunotherapy patients; level; serum level ... See more keywords
Association between serum baseline C1q and IgG levels and the efficacy of combined immunotherapy in patients with esophageal squamous cell carcinoma: a retrospective study
Sign Up to like & getrecommendations! Published in 2022 at "Immunopharmacology and Immunotoxicology"
DOI: 10.1080/08923973.2022.2115926
Abstract: Abstract Background To assess the clinical value of serum complement component 1q (C1q) and immunoglobulin G (IgG) levels in predicting the response to combined immunotherapy in patients with esophageal squamous cell carcinoma. Methods We conducted… read more here.
Keywords: combined immunotherapy; patients esophageal; esophageal squamous; immunotherapy patients ... See more keywords
Venom immunotherapy in patients with allergic reactions to insect stings
Sign Up to like & getrecommendations! Published in 2018 at "Expert Review of Clinical Immunology"
DOI: 10.1080/1744666x.2018.1413350
Abstract: ABSTRACT Introduction: Allergy to Hymenoptera (Apis mellifera, Vespula species, Polistes species, Vespa crabro) venom can be safely and effectively treated by venom immunotherapy (VIT), which in the 40 years since its introduction has been able… read more here.
Keywords: vit; patients allergic; venom immunotherapy; immunotherapy patients ... See more keywords
BESPOKE IO protocol: a multicentre, prospective observational study evaluating the utility of ctDNA in guiding immunotherapy in patients with advanced solid tumours
Sign Up to like & getrecommendations! Published in 2022 at "BMJ Open"
DOI: 10.1136/bmjopen-2021-060342
Abstract: Introduction Immunotherapy (IO) has transformed the treatment paradigm for a wide variety of solid tumours. However, assessment of response can be challenging with conventional radiological imaging (eg, iRECIST), which do not precisely capture the unique… read more here.
Keywords: ctdna; solid tumours; immunotherapy patients; treatment ... See more keywords
Immunotherapy for Patients with Advanced Urothelial Cancer: Current Evidence and Future Perspectives
Sign Up to like & getrecommendations! Published in 2017 at "BioMed Research International"
DOI: 10.1155/2017/5618174
Abstract: In recent years, immunotherapy has produced encouraging results in a rapidly increasing number of solid tumors. The responsiveness of bladder cancer to immunotherapy was first established in nonmuscle invasive disease in 1976 with intravesical instillations… read more here.
Keywords: bladder cancer; checkpoint inhibitors; immunotherapy patients; patients advanced ... See more keywords
Factors predicting the use of immunotherapy for patients with advanced melanoma.
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2018.36.15_suppl.9571
Abstract: 9571Background: Both pembrolizumab (PEMBRO) and the combination of ipilimumab and nivolumab (IPI+NIVO) are approved by the US FDA for treatment of advanced (unresectable or metastatic) melanoma. Cl... read more here.
Keywords: factors predicting; predicting use; advanced melanoma; use immunotherapy ... See more keywords
Immunotherapy for patients with advanced pancreatic carcinoma: a promising treatment
Sign Up to like & getrecommendations! Published in 2017 at "Oncotarget"
DOI: 10.18632/oncotarget.13968
Abstract: There are limited data on the safety and efficacy of immunotherapy for patients with advanced pancreatic cancer (APC). A meta-analysis of single-arm trials is proposed to assess the efficacy and safety of immunotherapy for APC.… read more here.
Keywords: immunotherapy; immunotherapy patients; treatment; months months ... See more keywords
Anti-angiogenesis boosts chemo-immunotherapy in patients with EGFR mutations or baseline liver metastases: insights from IMpower150 study
Sign Up to like & getrecommendations! Published in 2019 at "Translational cancer research"
DOI: 10.21037/tcr.2019.06.21
Abstract: The first-line treatment scenario of advanced non-small cell lung cancer (NSCLC) has been substantially revolutionized in the very last years, since immunotherapy has become a cornerstone. read more here.
Keywords: anti angiogenesis; immunotherapy patients; chemo immunotherapy; boosts chemo ... See more keywords
Cutaneous Adverse Reactions of Immunotherapy in Patients with Advanced Melanoma
Sign Up to like & getrecommendations! Published in 2023 at "Cancers"
DOI: 10.3390/cancers15072084
Abstract: Simple Summary It is estimated that 30–50 percent of patients treated with Immune Checkpoint Blockers will eventually develop cutaneous immune-related adverse events. These toxicities are in, most of the time, low-grade reactions; however, they are… read more here.
Keywords: adverse reactions; reactions immunotherapy; cutaneous adverse; immunotherapy patients ... See more keywords
Biomarkers for the Evaluation of Immunotherapy in Patients with Cholangiocarcinoma
Sign Up to like & getrecommendations! Published in 2025 at "Cancers"
DOI: 10.3390/cancers17030555
Abstract: Simple Summary Immunotherapy is now one of the therapeutic options for the treatment of unresectable or metastatic cholangiocarcinoma. Given the poor prognosis of this cancer type and the low response rate to immunotherapy, the application… read more here.
Keywords: evaluation immunotherapy; immunotherapy patients; treatment; biomarkers evaluation ... See more keywords
Automatic machine learning accurately predicts the efficacy of immunotherapy for patients with inoperable advanced non-small cell lung cancer using a computed tomography-based radiomics model
Sign Up to like & getrecommendations! Published in 2025 at "Diagnostic and Interventional Radiology"
DOI: 10.4274/dir.2024.242972
Abstract: PURPOSE Patients with advanced non-small cell lung cancer (NSCLC) have varying responses to immunotherapy, but there are no reliable, accepted biomarkers to accurately predict its therapeutic efficacy. The present study aimed to construct individualized models… read more here.
Keywords: immunotherapy patients; patients inoperable; advanced non; radiomics model ... See more keywords